Advertisement
Advertisement
PSNL
Personalis, Inc. Common Stock
6.39
USDSponsored
+0.35
+5.79%
May 13, 16:00 UTC -4
Closed
After-Market
6.50
+0.11
+1.72%
PSNL Earnings Reports
Positive Surprise Ratio
PSNL beat 19 of 28 last estimates.
68%
Next Report
Date of Next Report
Aug 03, 2026
Estimate for Q2 26 (Revenue/ EPS)
$17.27M
/-$0.27
Implied change from Q1 26 (Revenue/ EPS)
+11.63%
/-3.57%
Implied change from Q2 25 (Revenue/ EPS)
+0.40%
/+17.39%
Personalis, Inc. Common Stock earnings per share and revenue
On May 07, 2026, PSNL reported earnings of -0.28 USD per share (EPS) for Q1 26, missing the estimate of -0.27 USD, resulting in a -5.42% surprise. Revenue reached 15.47 million, compared to an expected 14.77 million, with a 4.73% difference. The market reacted with a -0.17% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 8 analysts forecast an EPS of -0.27 USD, with revenue projected to reach 17.27 million USD, implying an decrease of -3.57% EPS, and increase of 11.63% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Taysha Gene Therapies, Inc. Common Stock
Report Date
May 06, 2026 For Q1 26
Estimate
-$0.09
Actual
-$0.12
Surprise
-20.48%
Amphastar Pharmaceuticals, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.71
Actual
$0.42
Surprise
-41.59%
Assembly Biosciences, Inc
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.58
Actual
-$0.54
Surprise
+7.12%
Teva Pharmaceutical Industries Limited - ADR
Report Date
Apr 29, 2026 For Q1 26
Estimate
$0.48
Actual
$0.53
Surprise
+8.78%
BridgeBio Pharma, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.69
Actual
-$0.84
Surprise
-21.37%
Dr. Reddy's Laboratories Limited - ADR
Report Date
May 12, 2026 For Q4 26
Estimate
$11.40
Actual
$5.73
Surprise
-49.68%
Supernus Pharmaceuticals, Inc.
Report Date
May 05, 2026 For Q1 26
Estimate
$0.30
Actual
$0.60
Surprise
+97.69%
Bausch Health Companies Inc
Report Date
Apr 29, 2026 For Q1 26
Estimate
$0.69
Actual
$0.78
Surprise
+12.33%
FAQ
What were Personalis, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Personalis, Inc. Common Stock reported EPS of -$0.28, missing estimates by -5.42%, and revenue of $15.47M, 4.73% above expectations.
How did the market react to Personalis, Inc. Common Stock's Q1 2026 earnings?
The stock price moved down -0.17%, changed from $5.99 before the earnings release to $5.98 the day after.
When is Personalis, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 03, 2026.
What are the forecasts for Personalis, Inc. Common Stock's next earnings report?
Based on 8
analysts, Personalis, Inc. Common Stock is expected to report EPS of -$0.27 and revenue of $17.27M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement